SEC Form 4 · accession 0001193125-26-351801
AN2 Therapeutics, Inc. · ANTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph S Zakrzewski
Director
Period of report
Aug 14, 2026
Accepted (ET)
Aug 14, 2026 · 2:12 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001880438
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 14, 2026 | G | 405,880 | $0.00 | D | 0 | I | See footnote |
| Common Stock | holding | — | — | — | 145,538 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects a gift of shares to the children of the Reporting Person.
- F2The shares are held by Nancy Zakrzewski TTEE Z3 Trust U/A DTD 11/25/14 ("Z3 Trust"). The Reporting Person disavows beneficial ownership of the shares held by Z3 Trust.